Diabetology Xagena
A new study has found that three quarters of individuals with type 2 diabetes ( T2D ) who were treated with obesity surgery known as Roux-en-Y gastric bypass surgery ( RYGB ) experienced diabetes remi ...
A daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases ( NID ...
A treatment affecting the immune system effectively has slown the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded rese ...
People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Ins ...
Results of a new subgroup analysis from the phase 3 CREDENCE study, showing Canagliflozin ( Invokana ) has significantly reduced the risk of major cardiovascular ( CV ) events and kidney failure in pa ...
A study has assessed the efficacy and safety of iGlarLixi ( a titratable, fixed-ratio combination of Insulin glargine [ iGlar ] plus Lixisenatide ) in older patients with type 2 diabetes. The post ...
A study has investigated the association of diabetic retinopathy and neuropathy with increased risk of recurrent cardiovascular events in 6068 patients with type 2 diabetes mellitus ( T2DM ) and recen ...
Diabetic individuals commonly report disordered bowel habits. The aim of a study was to report the prevalence and associated factors of chronic diarrhea and chronic constipation in diabetics using a n ...
Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors ( SGLT-2i ) had lower rates of death and heart failure. Whether the benefits of SGLT-2 inhibitors vary based upon ...
A new Expert Consensus Decision Pathway issued by the American College of Cardiology ( ACC ) has recommended Empagliflozin ( Jardiance ) as the preferred SGLT2 inhibitor for its proven benefit in redu ...
The results from PIONEER 8, a phase 3a trial with oral Semaglutide ( Ozempic ) for the treatment of adults with type 2 diabetes. Oral Semaglutide is an investigational GLP-1 analogue taken once dail ...
Researchers have systematically evaluated the efficacy and safety of Lixisenatide ( Lyxumia ) in patients with type 2 diabetes mellitus. Fourteen multicenter randomized controlled trials involving ...
New research presented at the annual meeting of the European Association for the Study of Diabetes ( EASD ) has shown how the glucose-lowering drug Lixisenatide ( Lyxumia ) can slow or prevent damage ...
Dulaglutide ( Trulicity ) significantly improves A1C ( average blood sugar concentration over two to three months ) when added to ongoing treatment with a sodium-glucose co-transporter-2 ( SGLT-2 ) in ...
Both type 1 ( T1DM ) and type 2 diabetes mellitus ( T2DM ) have been associated with bone fragility and increased fracture risk. However, little is known regarding the effect of anti-osteoporotic tr ...
